đŹ Current Disease Focus:
Task Progress: 0%
đĽ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
𧪠Experimental Design
đŹ Clinical Trials
đ Treatment Development
Vaccines are one of our most effective public health tools but many who nee...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2014-04
Trial ID
NCT02057263
Treatments Being Tested
A study to evaluate the safety, tolerability, and immunogenicity of a recom...
Status
Completed
Location
Multiple Locations
Start Date
2005-06
Trial ID
NCT00489099
This is a study to assess the safety, tolerability, and immunogenicity of V...
Status
Completed
Location
Multiple Locations
Start Date
2011-04-19
Trial ID
NCT01337167
Treatments Being Tested
This study is being done to determine if healthcare workers who have previo...
Status
Completed
Location
University of Wisconsin
Start Date
2020-09-15
Trial ID
NCT04456504
Treatments Being Tested
The first purpose of this study is to test the body's protective reaction (...
Status
Completed
Location
University of Maryland, Baltimore, Center for Vaccine Development and Global Health
Start Date
2000-03-29
Trial ID
NCT04162223
Treatments Being Tested
This study was conducted in healthy infants and will provide new immunogeni...
Status
Completed
Location
Multiple Locations
Start Date
2006-10-06
Trial ID
NCT00414050
The purpose of this trial is to determine if there is an improvement in the...
Status
Completed
Location
Multiple Locations
Start Date
2006-11
Trial ID
NCT00440531
The purpose of this study is to evaluate the safety, tolerability, and immu...
Status
Completed
Location
Alabama Clinical Therapeutics ( Site 0159)
Start Date
2019-06-19
Trial ID
NCT03893448
Treatments Being Tested
This is a study to evaluate immunogenicity, safety, and tolerability of 2XP...
Status
Completed
Location
Multiple Locations
Start Date
2011-11-29
Trial ID
NCT01463683
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability and immun...
Status
Completed
Location
Multiple Locations
Start Date
2001-05
Trial ID
NCT00551915
Treatments Being Tested